Kostmann’s syndrome-treatment is
**Core Concept**
Kostmann's syndrome is a rare genetic disorder characterized by severe congenital neutropenia, where the bone marrow fails to produce enough neutrophils, leading to recurrent infections and increased susceptibility to infections.
**Why the Correct Answer is Right**
The treatment for Kostmann's syndrome involves administering recombinant human granulocyte colony-stimulating factor (G-CSF), which stimulates the bone marrow to produce more neutrophils. This is because the disorder is caused by mutations in the ELA2 gene, which codes for the neutrophil elastase enzyme. G-CSF is effective in increasing neutrophil counts and reducing the frequency of infections in patients with Kostmann's syndrome.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because corticosteroids are not the primary treatment for Kostmann's syndrome. While corticosteroids may be used to manage some symptoms, they do not address the underlying cause of the disorder.
* **Option B:** This option is incorrect because antibiotics are not a substitute for the underlying treatment of G-CSF. Antibiotics may be used to treat infections, but they do not prevent the development of severe infections due to neutropenia.
* **Option C:** This option is incorrect because bone marrow transplantation is a treatment option for some cases of severe congenital neutropenia, but it is not the first-line treatment for Kostmann's syndrome.
**Clinical Pearl / High-Yield Fact**
It's essential to recognize that Kostmann's syndrome is a distinct clinical entity that requires specific treatment. G-CSF is the cornerstone of treatment, and its administration can significantly improve outcomes for patients with this disorder.
**Correct Answer: B. G-CSF (Granulocyte Colony-Stimulating Factor)**